Rimedile Pharmaceutical Private Limited
About Rimedile Pharmaceutical Private Limited
Data last updated:
Rimedile Pharmaceutical Private Limited is a private limited company based in Ghaziabad, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 23 June 2022.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U51909UP2022PTC166290.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Atul Gupta and Rikesh Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 15 Indirapuri Loni, Ghaziabad, Uttar Pradesh, India – 201102.
As per the financials filed for FY 2024, the company reported a revenue of ₹30.32 Lakh, a growth of 72% compared to the previous year. For the same year it recorded a net profit of ₹37,390 (net margin 1.2%) and EBITDA of ₹71,727 (EBITDA margin 2.4%).
Company details
Contact details
Rimedile Pharmaceutical Private Limited's registered office is in Ghaziabad, Uttar Pradesh.
- Registered AddressA – 15 Indirapuri Loni, Ghaziabad, Uttar Pradesh, India – 201102
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Rimedile Pharmaceutical is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products |
To see the full business activity and turnover split of Rimedile Pharmaceutical Private Limited, buy the company report.
Financials of Rimedile Pharmaceutical Private Limited
FY 2025 filings availableRimedile Pharmaceutical Private Limited reported revenue of ₹30.32 Lakh (up 72% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 72% in the latest year. EBITDA fell 12% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹71,727 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹37,390 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 2.4% | |
| Net Profit Margin | 1.2% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Rimedile Pharmaceutical Private Limited, buy the company report.
Board of directors of Rimedile Pharmaceutical Private Limited
Rimedile Pharmaceutical has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Atul Gupta | Director | 23 Jun 2022 | 4 Years 4 Months | Current |
| Rikesh Kumar | Director | 23 Jun 2022 | 4 Years 4 Months | Current |
Legal cases
No court or tribunal cases involving Rimedile Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rimedile Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Rimedile Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Rimedile Pharmaceutical Private Limited has 3 board changes on record since 2022: 2 appointments and 1 cessation. The latest: Satendra Singh ceased to be Director on 27 Nov 2024.
Frequently asked questions
Rimedile Pharmaceutical is an active private limited company based in Ghaziabad, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 23 June 2022 (4+ years old) and is registered under CIN U51909UP2022PTC166290.
Rimedile Pharmaceutical has 2 current directors:
- Atul Gupta - Director
- Rikesh Kumar - Director
The latest financial statements of Rimedile Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Rimedile Pharmaceutical is U51909UP2022PTC166290. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rimedile Pharmaceutical was incorporated on 23 June 2022, making it 4+ years old. It is registered with the Registrar of Companies, Kanpur.
Satendra Singh ceased to be Director on 27 Nov 2024. Atul Gupta was appointed as Director on 23 Jun 2022. Rikesh Kumar was appointed as Director on 23 Jun 2022.
The registered office of Rimedile Pharmaceutical is at A – 15 Indirapuri Loni, Ghaziabad, Uttar Pradesh, India – 201102.
Rimedile Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Rimedile Pharmaceutical can be reached at its registered office: A – 15 Indirapuri Loni, Ghaziabad, Uttar Pradesh, India – 201102.
Rimedile Pharmaceutical is registered under the jurisdiction of the Registrar of Companies (ROC), Kanpur.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
